Loading…
← CockpitCompetitor Analysis › MCOV-B.ST Medicover AB Class BOpen in the cockpit ↗

Medicover AB Class BMCOV-B.STCompetitor analysis, valuation and peers

Sweden · SEK·Health Care›Medical/Nursing Services

Healthcare services provider operating clinics, diagnostics labs and hospitals across Central/Eastern Europe and Germany.

≈ A CEE healthcare-services network like a smaller HCA Healthcare/LabCorp hybridMomentum strong 71
Mkt cap
$3.87B
US dollars, full cap
Free float
89%
of shares outstanding
$/day
$2.28M
20-day average traded
Fwd P/E
36.1×
forward earnings
ROIC−WACC
-1.5 pp
WACC 9.5%
Hurdle
-1 pp
Req g minus delivered
Next earnings
84 days
10 Feb 2027
Close · SEKSEK 259.00
1D+0.4%
1W-1.5%
1M-2.6%
3M+7.7%
6M+21.3%
YTD+17.5%
1Y+8.6%
ATR %2.4%
52w lowhigh9.0% off high

What Medicover does

Healthcare services provider operating clinics, diagnostics labs and hospitals across Central/Eastern Europe and Germany.

Paid partly through prepaid subscription plans that employers buy for their staff, partly by fee per visit or test, and partly by public health insurers. Listed in Stockholm, but its clinics, hospitals and laboratories are in other European countries.

In one line: A CEE healthcare-services network like a smaller HCA Healthcare/LabCorp hybrid.

Products and services

  • Outpatient clinic services
  • Diagnostic laboratory testing
  • Hospital care (select markets)
  • Corporate health insurance/benefits

Customers

  • Patients
  • Corporate healthcare-benefit clients
  • Insurers

Where it sits in the supply chain

  • Health Care
  • Healthcare services
  • Outpatient clinics, diagnostics and…

What could go right

  • Private healthcare penetration growth in CEE
  • Corporate health-benefit contract growth

What could go wrong

  • Healthcare regulation/reimbursement changes across countries
  • Staffing cost inflation

Moat: narrow (scale, brand, installed base). Largest private healthcare network in several CEE markets, benefiting from scale and brand trust in fragmented markets.

Headquarters: Stockholm, Sweden · Founded: 1995

Named competitors

Medicover at a glance

Size Medicover (MCOV-B.ST) is a Sweden Health Care company (Medical/Nursing Services) with a market value of $3.87B, the 51st largest of 220 Sweden companies the cockpit tracks. Shares closed at SEK 259.00 on 18 Nov 2026.

Performance Over six months the shares gained 21.3%, against +28.9% for the median peer and +2.8% for the Sweden market (cap-weighted) — 10th lowest of 20 in its peer set.

Growth Revenue grew 2.6% over the last twelve months (peer median +11.7%); the operating margin is 7.5% (peer median 8.9%).

Valuation It trades at 36.1× forward earnings against a peer median of 39.0× (9th cheapest of 18).

Price implies For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.5 points below its cost of capital (9.5% WACC).

Next results Next results expected around 10 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026Peer median 130MCOV-B.ST 122
Six months, rebased to 100: Medicover against the median of its 20 peers (local-currency closes).

Medicover financials

Reported figures in SEK; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueSEK 26.7BSEK 26.3BSEK 23.9BSEK 20.0BSEK 16.1B
Revenue growth—+10%+19%+25%—
Gross profitSEK 6.32BSEK 6.10BSEK 4.57BSEK 3.58BSEK 3.15B
EBITDASEK 4.41BSEK 4.11BSEK 3.29BSEK 2.81BSEK 2.39B
Net incomeSEK 994MSEK 858MSEK 191MSEK 202MSEK 126M
Free cash flowSEK 1.45BSEK 1.43BSEK 981MSEK 597M-SEK 10.6M
Capital expenditureSEK 1.58BSEK 1.75BSEK 1.40BSEK 1.27BSEK 1.50B
Total debtSEK 14.3BSEK 15.6BSEK 13.6BSEK 11.0BSEK 10.1B

Quarterly statements and history in the cockpit →

Medicover competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%+150%-25%0%+25%HIMSLALPATHLABACHCBLLNOPCHLFSTCONRDNT002044MDAVAHSHLAZTANEOAGARWALEYE603882EMEISMCOV-B.ST6-month return →1-month return →
Up and to the right = strong over both horizons. Medicover is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%50×100×LALPATHLABACHCBLLNOPCHLFSTCONRDNT002044MDAVAHSHLALIF-BAZTANEOAGARWALEYE603882MCOV-B.STRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Medicover is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%75%LALPATHLABBLLN3774OPCHLFSTCONRDNTMDAVAHSHLALIF-BAZTAAGARWALEYE603882EMEISMCOV-B.STGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Medicover is the large dot.

Medicover competitors and peer comparison

Head to head with its named competitors (MCOV-B.ST vs FRE.DE vs SHL.AX)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Medicover MCOV-B.ST$3.87B+21%+3%7%36.1×19.6%
Fresenius SE & Co. KGaA FRE.DE$32.7B+41%+7%10%14.7×7.0%
Sonic Healthcare SHL.AX$6.87B+6%+14%9%17.4×9.1%

How Medicover compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Medicover against its 20 peers (data as of 18 Nov 2026)
MeasureMCOV-B.STPeer medianRank in peer set
1-month return-2.6%+2.8%8th lowest of 21
6-month return+21.3%+28.9%10th lowest of 20
Distance from 52-week high-9.0%-12.9%10th highest of 21
Revenue growth (TTM)+2.6%+11.7%5th lowest of 21
Operating margin7.5%8.9%9th lowest of 21
Forward P/E36.1×39.0×9th cheapest of 18
Growth the price implies (Req g, 7 yrs)19.6%21.1%9th least demanding of 18
Growth delivered (Del g)+20.2%+11.8%5th highest of 18
Hurdle (Req g minus delivered)-0.7 pp+5.6 pp8th least demanding of 18
ROIC minus cost of capital-1.5 pp-0.0 pp11th highest of 21
EV / EBITDA12.0×15.4×6th cheapest of 16
Net debt / EBITDA3.0×2.6×8th most indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Hims & Hers Health HIMSUnited States$4.00B-26%+30%-1%n/an/an/a
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
BillionToOne BLLNUnited States$4.37B+7%+72%10%115.3×22.8%+71.9%
Fameglow 3774.HKHong Kong$4.54Bn/a+36%11%n/a57.4%+48.4%
Option Care Health OPCHUnited States$4.75B+43%+4%6%15.7×2.0%+13.2%
Lifestance Health LFSTUnited States$5.24B+79%+23%6%51.8×33.4%+30.4%
Concentra Group Holdings Parent CONUnited States$5.31B+65%+12%17%22.3×3.6%+7.9%
RadNet RDNTUnited States$5.66B+32%+21%5%93.2×38.8%+13.7%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
Sonic Healthcare SHL.AXAustralia$6.87B+6%+14%9%17.4×9.1%+3.5%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Azenta AZTAUnited States$2.03B+162%+5%-2%83.2×38.0%+3.9%
NeoGenomics NEOUnited States$1.98B+72%+11%-6%53.5×n/an/a
Dr. Agarwal's Health Care AGARWALEYE.NSIndia$1.86B+20%+26%15%77.1×43.0%+26.9%
Guangzhou Kingmed Diagnostics 603882.SSChina$1.86B+5%-3%7%29.9×5.4%-6.1%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%

Questions

Who are Medicover's main competitors?
Named competitors: Fresenius Helios (Fresenius SE) (FRE.DE), Mediclinic International (private) (private or unlisted), LuxMed (private) (private or unlisted), Sonic Healthcare (SHL.AX), Alab Laboratoria (private or unlisted). The cockpit's measured peer set (industry) also includes Hims & Hers Health (HIMS), Dr. Lal PathLabs (LALPATHLAB.NS), Acadia Healthcare (ACHC), BillionToOne (BLLN), Fameglow (3774.HK), Option Care Health (OPCH).
Is Medicover expensive compared with its peers?
On forward p/e it trades at 36.1× against a peer median of 39.0×, 9th cheapest of 18 in its peer set. For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Medicover stock performed?
Over six months to 18 Nov 2026 the shares returned +21.3% against +28.9% for the median peer; over one year +8.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.